Clinical Trial Update: Long-term Safety and Efficacy Study of Octreotide Implant in Patients With Acromegaly [Phase 3]

View source ↗

Summary

A Phase 3 long-term safety and efficacy study of an octreotide implant for acromegaly has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acromegaly

Drugs mentioned

• Octreotide Implant (octreotide)

Snippet

Sponsor: Endo Pharmaceuticals | Conditions: Acromegaly | Phase 3 | Status: TERMINATED